Introduction
Otosclerosis, also known as otospongiosis, is a disease characterized by progressive hearing loss caused by pathologic bone remodeling of the bony labyrinth, especially the otic capsule [
1,
2]. The disease mainly involves decreased mobility of the stapedial foot plate leading to conductive hearing loss. As the disease progresses, the bony labyrinth undergoes remodeling and causes a mixed type of hearing loss on audiogram. Patients usually present with hearing impairment, but the presenting symptom could be dizziness, tinnitus or other otologic symptoms.
Otosclerosis is found in 12% of the Caucasian population but is less common in African and Asian populations. It is also found to be 1.5 times to 2 times more prevalent in females [
2,
3]. In Korea, otosclerosis is a clinically rare disease; thus, many patients may either be underdiagnosed or misdiagnosed. There are also few studies about otosclerosis in Korean; only one previous case about siblings with otosclerosis in Korea has been reported [
4].
Osteogenesis imperfecta (OI) is a heritable syndrome characterized by one or more of the features of osteoporosis leading to fractures, blue sclera, hyperlaxibility, and impaired hearing present throughout life. Hearing impairment is a common finding in the patients diagnosed with OI [
5]. In this study, we report two cases of otosclerosis with OI and their management.
Discussion
The diagnosis of otosclerosis can be made histopathologically after stapedeotomy or stapedectomy. However, the diagnosis is usually made clinically by history, physical examination, audiogram results, and temporal bone CT. Sixty percent of patients suffering from otosclerosis report familial history, as seen in our cases [
1]. The disease has an autosomal-dominant inheritance pattern with an incomplete penetration. With the advancement of radiologic technique, high-resolution CT (HRCT) has been used for diagnosis and surgical management of otosclerosis [
1]. Typical findings on HRCT include radiolucency within the otic capsule, thickening of the stapes, and demineralization of the area outlining the cochlea (“double-ring” sign), as seen in patient 1. These features have high diagnostic sensitivity and specificity.
OI is a hereditary syndrome resulting from genetic mutation of collagen production and secretion. OI was originally classified by Sillence into four types according to inheritance, features, and severity [
5]. The most frequent type of OI encountered by otolaryngologists is OI type I, which is due to mutations in the
COL1A1 or
COL1A2 gene. Patients with OI present with repeated fractures and hearing impairment, as seen in our cases; hence, OI is a known risk factor for otosclerosis. However, there is no association between the genotype and hearing ability. A previous review of the histopathological changes of temporal bones of patients diagnosed with OI through the National Temporal Bone Registry database of America described the temporal bone lesions and their implications on the observed heterogeneity of hearing loss patterns [
6]. The otopathologic changes in otosclerosis cases vary from histologic otosclerosis to the fixation of the foot plate of stapes and even cochlear otosclerosis [
6,
7].
Surgery is an effective option for the management of otosclerosis. Stapedotomy or stapedectomy increases the mobility of the involved stapedial foot plate [
8]. It should be considered in patients with conductive hearing loss of 20 dB or more, PB max of 60% or more, and with fair general condition. However, patients must be informed that otosclerosis is a progressive disease even with successful surgery. Around 10-20% of patients may need to undergo reoperation [
9,
10]. Meanwhile, hearing aid technology could also be a good treatment option for patients who are unbale to undergo surgery or who have sensorineural hearing loss of 25 dB or more [
1].
Furthermore, due to the advancement in hearing rehabilitation surgery, middle ear implant (MEI), bone conduction implant, and cochlear implant (CI) could be successful alternative treatment options for otosclerosis [
11]. MEI could be an effective surgical option in patients with intact ossicle mobility; hence, this surgery is performed with or after stapedial surgery [
12]. Physicians may consider bone conduction implant in patients with mixed type hearing impairment or mild sensorineural hearing loss. However, in these cases, hearing aids must be tried first. CI could be a successful strategy for advanced cases. However, factors such as the structural change of the inner ear and the possibility of reoperation must be considered before surgery [
13,
14].
Some physicians recommend oral administration of sodium fluoride due to its antagonistic effect on bone remodeling and osteoclastic activation. However, there is no clinical consensus on this [
15]. Some studies have been conducted on bisphosphonate and vitamin D derivatives, but have not proven established treatment modalities for otosclerosis [
15].
Treatment for OI type I mainly focuses on the prevention of fractures, physical therapy, and rehabilitation exercise. The risks of fracture decreases after adolescence, and, usually, there is no need for regular follow-up on skeletal concerns. However, patients with OI may have progressive impairment. For this reason, otolaryngologists should regularly follow-up patients to provide an appropriate treatment strategy at the earliest.
In both our cases, we could easily diagnose otosclerosis clinically without genotyping. Patient 2 had already been diagnosed with OI. Patient 1 had not yet been diagnosed with OI before. However, given her childhood history of repeated fractures, we presume that she also had OI. Therefore, both cases had OI as a risk factor for otosclerosis and both were informed of the need for regular follow-ups because of the progressive nature of the disease. In patient 1, the patient’s audiogram showed moderate hearing impairment of both ears with conductive hearing loss of the left ear. Our treatment strategy for patient 1 was the use of a hearing aid. Hearing aids can be beneficial alternative treatment options due to their cost-effectiveness and non-invasiveness. Patient 2 had no otologic symptoms and there was also no evidence of hearing disability on audiogram. However, there was an evidence of demineralization change on both cochlea but not in fissula ante fenestram.
The difference in their hearing level maybe related with the difference in their CT findings. The greater the demineralization of the otic capsule and fissula ante fenestram, the more advanced the hearing loss. Based on their CT findings and audiograms, we recommend CT for both patients in addition to PTA to search for development or progression of otologic symptoms and development of demineralization of area of fissula ante fenestram in the case of patient 2.
It is important to regularly follow-up patients with otosclerosis not only with audiograms but also with CT. This will enable the clinicians to provide timely medico-surgical management prior to recognition of the impairment of their hearing ability.